Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

NCT02756663 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: panobinostat (capsules)
DRUG: carfilzomib (infusion)
DRUG: dexamethasone (tablets)

Sponsor

Novartis Pharmaceuticals